Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
200 hedge funds and large institutions have $5.01B invested in Intercept Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 78 increasing their positions, 53 reducing their positions, and 23 closing their positions.
135% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 23
107% more capital invested
Capital invested by funds: $2.42B → $5.01B (+$2.58B)
47% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 53
18% more funds holding
Funds holding: 169 → 200 (+31)
14% more call options, than puts
Call options by funds: $257M | Put options by funds: $225M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$161M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$82.1M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$78.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$60M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$59.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$79M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$68M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$36.4M |
| 4 |
Millennium Management
New York
|
-$23.5M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21M |
ICPT Hedge Fund Activity: Q1 2015 in Review
200 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q1 2015, worth a combined $5.01B — up 107% from $2.42B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new ICPT positions and 23 closed out — a net gain of 31 holders — while 78 added to existing stakes and 53 trimmed.
The largest buyer was Ameriprise, adding an estimated $161M. The largest seller was OrbiMed, cutting an estimated $79M.
- 200 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q1 2015, up from 169 in Q4 2014.
- Funds reported $5.01B of Intercept Pharmaceuticals, Inc. stock for Q1 2015, up 107% quarter-over-quarter.
- 54 funds opened new Intercept Pharmaceuticals, Inc. positions in Q1 2015 and 23 closed out, a net change of +31 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q1 2015 was Ameriprise, an estimated $161M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q1 2015 was OrbiMed, an estimated $79M sold.
Based on aggregated 13F filings for Q1 2015.